LENZ Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
LENZ Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2022 to Q3 2024.
  • LENZ Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -64.7 %, a 170% decline year-over-year.
  • LENZ Therapeutics, Inc. annual Return On Assets for 2023 was -53.4 %, a 83.5% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -64.7 -40.8 -170% Jul 1, 2024 Sep 30, 2024
Q2 2024 -65.6 -41.2 -168% Apr 1, 2024 Jun 30, 2024
Q1 2024 -61.2 -34.6 -130% Jan 1, 2024 Mar 31, 2024
Q4 2023 -53.4 -24.3 -83.5% Oct 1, 2023 Dec 31, 2023
Q3 2023 -23.9 +2.05 +7.89% Jul 1, 2023 Sep 30, 2023
Q2 2023 -24.5 -2.46 -11.2% Apr 1, 2023 Jun 30, 2023
Q1 2023 -26.6 -7.2 -37.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -29.1 Oct 1, 2022 Dec 31, 2022
Q3 2022 -26 Jul 1, 2022 Sep 30, 2022
Q2 2022 -22 Apr 1, 2022 Jun 30, 2022
Q1 2022 -19.4 Jan 1, 2022 Mar 31, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.